@MidCapDiverse Portfolio Update - Q1 2026
We are in the first days of 2026, and the first days of a new quarter, so it’s time again to update our portfolio with a new set of 20 mid-cap stocks selected by our AI analysis for growth potential that mitigates risk.
Yet again, we saw shifts in the sector distribution of the portfolio, with the update’s leading sectors as follows:
🔹Consumer Discretionary - 20.7%
🔹Energy - 17.2%
🔹Health Care - 17.2%
Consumer Discretionary is yet again at the top of the list and also represents 20% of the portfolio as it did in the previous quarter. However, this time both Energy and Health Care now take the second and third spots, significantly increasing their weight in the portfolio from last quarter.
Let’s take a look at those two sectors and understand what could be driving their growth in the portfolio this quarter.
📈Energy
The Energy sector in Q1 2026 is set for continued growth in demand, with U.S. electricity sales projected to rise by 2.6%. This uptick is fueled by heavy data center, AI, and crypto development, especially in Texas and the Mid-Atlantic. Wholesale power prices are expected to increase about 8.5% year-over-year, reaching around 51 USD/MWh, while natural gas remains a key driver—Henry Hub prices are forecast to average roughly 4.00 USD/MMBtu, up 16% from 2025, and could climb to nearly 4.30 USD/MMBtu during the winter.
Renewables are gaining ground, expected to supply around 26% of U.S. generation by 2026, as natural gas and coal lose share. Investment is flowing into scalable, stable energy infrastructure, with a strong focus on renewables and grid modernization to support economic and climate goals. Meanwhile, global oil prices are forecast to soften, with Brent crude averaging 55 USD/barrel in Q1 2026, reflecting rising global inventories.
📈Health Care
The Health Care sector in Q1 2026 faces a landscape shaped by both significant challenges and new growth opportunities.
AI adoption is accelerating, promising greater efficiency, faster drug development, and lower costs for providers and biopharma companies. Mergers and acquisitions are expected to ramp up, especially among biotech and medtech firms seeking scale and innovation. The sector is also seeing a shift toward lower-acuity and home-based care, as organizations look to expand reach and manage costs through hybrid models.
However, the sector must navigate substantial headwinds: the One Big Beautiful Bill (OBBB) Act will cut an estimated 911 billion USD from Medicaid over the next decade, with nearly 500 billion USD in Medicare cuts expected to follow starting in 2027. This will pressure margins and force providers to rethink care delivery and reimbursement models. Persistent workforce shortages and cybersecurity threats add further complexity.
Despite these pressures, opportunities remain in automation, value-based care, and targeted regional M&A. Organizations that leverage AI and adapt to the changing regulatory and funding environment are best positioned to thrive in early 2026.... Show More
We use our own and third-party cookies on our websites to enhance your experience, analyze traffic, and for security and marketing. For more info, see our Cookie Policy or go to Manage Settings.
Privacy Preference Center
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
More information
Manage Consent Preferences
Strictly Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Cookie List
label
ConsentLeg.Interest
label
label
label
Fri Mar 13 2026 01:49:50 GMT+0000 (Coordinated Universal Time)
